Bank Of The West Biogen Inc. Transaction History

Bank Of The West

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$220.06 - $304.07 $561,813 - $776,290	-2,553 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$217.44 - $243.88 $206,350 - $231,442	-949 Reduced 27.1%	2,553 $595,000
Q2 2019 Jul 18, 2019	SELL	$219.29 - $241.72 $2.05 Million - $2.26 Million	-9,335 Reduced 72.72%	3,502 $819,000
Q1 2019 Apr 09, 2019	SELL	$216.71 - $338.96 $437,537 - $684,360	-2,019 Reduced 13.59%	12,837 $3.04 Million
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $125,325 - $158,737	-450 Reduced 2.94%	14,856 $4.47 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $107,131 - $140,097	-365 Reduced 2.33%	15,306 $5.41 Million
Q2 2018 Jul 25, 2018	SELL	$257.52 - $306.91 $106,098 - $126,446	-412 Reduced 2.56%	15,671 $4.55 Million
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $610,004 - $862,748	-2,345 Reduced 12.73%	16,083 $4.4 Million
Q4 2017 Feb 05, 2018	SELL	$307.64 - $344.58 $1.18 Million - $1.32 Million	-3,820 Reduced 17.17%	18,428 $5.87 Million
Q3 2017 Oct 17, 2017	BUY	$281.15 - $329.69 $6.26 Million - $7.33 Million	22,248	22,248 $6.97 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Bank Of The West, based on Form 13F filings with the SEC.

Stay updated on Bank Of The West with notifications on news.